Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets.

CONTEXT The detection of exogenously administered growth hormone (GH) poses a formidable challenge but a detection method based on the measurement of two GH-dependent markers, IGF-I and type 3 pro-collagen (P-III-P) has been proposed. The measurement of multiple markers in conjunction with discriminant functions can improve the sensitivity and specificity of detection compared with single marker analysis. OBJECTIVE To provide further validation of the GH-dependent marker approach. DESIGN Analysis of discriminant function scores for GH detection on independent datasets. SETTING Two independent (GH-2000 and Kreischa) double blind, placebo controlled, hGH administration studies. SUBJECTS Healthy active male volunteers. INTERVENTION GH-2000 proposed a discriminant function involving IGF-I and P-III- P while the Kreischa function involved IGF-I, P-III-P and IGFBP-3. After adjustment for assay differences the formulae were applied to the other dataset. OUTCOME MEASURES Ability to detect GH use in independent datasets using a predefined specificity of approximately 1 in 10000. RESULTS The GH-2000 formula was able to detect 90% of those receiving GH in the Kreischa study at one or more time points during the study period. This sensitivity was similar to that obtained on the original GH-2000 dataset. The Kreischa formula correctly identified 41% of individuals receiving GH in the GH-2000 study. CONCLUSIONS The study provides further validation that the test proposed by GH-2000 based on IGF-I and P-III-P concentrations can be used to detect subjects receiving exogenous GH.

[1]  P. Sönksen,et al.  The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. , 2000, The Journal of clinical endocrinology and metabolism.

[2]  Ian Goodall,et al.  HbA1c standardisation destination--global IFCC Standardisation. How, why, where and when--a tortuous pathway from kit manufacturers, via inter-laboratory lyophilized and whole blood comparisons to designated national comparison schemes. , 2005, The Clinical biochemist. Reviews.

[3]  A. Juul IGF-I Measurements , 2005 .

[4]  H. Orskov,et al.  Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. , 1999, The Journal of clinical endocrinology and metabolism.

[5]  H. Koistinen,et al.  Growth hormone induced increase in serum IGFBP‐3 level is reversed by anabolic steroids in substance abusing power athletes , 1998, Clinical endocrinology.

[6]  M. Bidlingmaier,et al.  Test method: GH. , 2000, Bailliere's best practice & research. Clinical endocrinology & metabolism.

[7]  N. Skakkebaek,et al.  Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle. , 1997, Human reproduction.

[8]  C. Yesalis,et al.  Performance Enhancing Substances in Sport and Exercise , 2002 .

[9]  R. Baxter,et al.  Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex. , 2000, The Journal of clinical endocrinology and metabolism.

[10]  J. Kratzsch,et al.  Potential parameters for the detection of hGH doping , 2003, Analytical and bioanalytical chemistry.

[11]  P. Sönksen,et al.  Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. , 2005, The Journal of clinical endocrinology and metabolism.

[12]  L. Saccá,et al.  Growth Hormone (GH) Effects on Bone and Collagen Turnover in Healthy Adults and Its Potential as a Marker of GH Abuse in Sports: A Double Blind, Placebo-Controlled Study , 2000 .

[13]  Peter H. Sönksen,et al.  Insulin, growth hormone and sport. , 2001 .

[14]  P. Sönksen,et al.  Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. , 2000, The Journal of clinical endocrinology and metabolism.

[15]  Jordi Segura,et al.  Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport , 2005, Clinical chemistry and laboratory medicine.

[16]  R. Baxter,et al.  The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. , 2003, The Journal of clinical endocrinology and metabolism.

[17]  J. Wallace,et al.  Growth hormone and sport , 2000 .

[18]  P. Preux,et al.  Epidemiological and clinical aspects. , 2005 .